Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

STAPHCILLIN

METHICILLIN SODIUM

Standard Dose
EQ 900MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview STAPHCILLIN is listed in Drugs@FDA under application 061449 (ANDA).

Marketing status: Discontinued Active ingredient METHICILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 900MG BASE/VIAL Sponsor APOTHECON Submission history Latest submission status date: 1991-05-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview STAPHCILLIN is listed in Drugs@FDA under application 061449 (ANDA). Marketing status: Discontinued Active ingredient METHICILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 900MG BASE/VIAL Sponsor APOTHECON Submission history Latest submission status date: 1991-05-21 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.